CCCC C4 Therapeutics, Inc.
$3.51▲ +3.24%
Healthcare
Other
After hours
$3.50▼ -0.28%
Sep 11, 7:30 PM ET
Volume 1.46M
Avg Volume (10D) 1.92M
Key Metrics & Fundamentals
Market Cap
$431.82M
P/E Ratio
–
Div Yield
–%
52W Range
1.69 - 5.17
% vs 50 MA
-8.54%
% vs 200 MA
14.52%
RSI-14
39.9
MACD Histogram
-0.0700
Beta (1Y vs SPY)
1.91
Free Cash Flow
-$1.61M
Gross Rev
$6.64M
Gross Profit
$6.64M
EBITDA
-$26.13M
COGS
–
Operating Exp
$33.06M
Operating Income
-$26.42M
EBIT
-$26.42M
Pretax Income
-$23.64M
Net Income
-$23.64M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
GlobeNewswire · Sep 3, 2026 11:00 AM
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice
Zacks · Aug 21, 2026 4:00 PM
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 12:15 PM
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 11, 2026 11:00 AM
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 10, 2026 8:01 PM
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
Zacks · Jul 7, 2026 1:40 PM
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know
Zacks · Jul 3, 2026 4:00 PM
C4 Therapeutics (CCCC) Gains Over the Past Month, Can It Go Higher?
Insider Monkey · Jul 3, 2026 1:11 PM
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Zacks · Jun 18, 2026 1:40 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CCCC's money flow as a full page
Social Sentiment
No Reddit posts found for CCCC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.